(Q34711457)

English

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Razelle Kurzrock

12

object named as

Razelle Kurzrock

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

object named as

Siqing Fu

1

0 references

object named as

Robert C Bast

13

0 references

Charles F. Levenback

6

object named as

Charles F Levenback

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Bryan T. Hennessy

11

object named as

Bryan T Hennessy

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

David Gershenson

9

object named as

David M Gershenson

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

7

object named as

Anil K Sood

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Wei Hu

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Revathy Iyer

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

John J Kavanagh

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Robert L Coleman

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Judith K Wolf

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Maurie Markman

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

0 references

publication date

8 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

117

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1661-1669

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

DNA hypomethylation in cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Epigenetic therapies for chemoresensitization of epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

The promises and pitfalls of epigenetic therapies in solid tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Differential methylation profile of ovarian cancer in tissues and plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Pharmaceutical management of ovarian cancer : current status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

The management of recurrent ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Cancer epigenomics: DNA methylomes and histone-modification maps

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Identification of candidate methylation-responsive genes in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

The epigenetics of ovarian cancer drug resistance and resensitization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Carboplatin reinduction after taxane in patients with platinum-refractory epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3062960

7 July 2018

Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25701

21 January 2018

Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25701

21 January 2018

The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25701

21 January 2018

Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25701

21 January 2018

Alternate molecular genetic pathways in ovarian carcinomas of common histological types.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25701

21 January 2018

Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25701

21 January 2018

Promoter hypermethylation profile of ovarian epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25701

21 January 2018

Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter

1 reference

https://pubmed.ncbi.nlm.nih.gov/21472713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21472713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA methylation and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21472713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-line therapy for ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21472713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21472713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors

2 references

https://pubmed.ncbi.nlm.nih.gov/21472713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

https://api.crossref.org/works/10.1002%2FCNCR.25701

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian cancer. Clinical practice guidelines in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/21472713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A change in promoter methylation of hMLH1 is a cause of acquired resistance to platinum-based chemotherapy in epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21472713

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.25701

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

release_3tau52kzsncljihvwnn7rbmlzm

1 reference

https://api.fatcat.wiki/v0/release/3tau52kzsncljihvwnn7rbmlzm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34711457&oldid=2034413711"